• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Squamous cell carcinoma in situ upstaging is not frequent in the nail unit: a tertiary cancer center experience.原位鳞状细胞癌在指甲单元中并不常见:来自三级癌症中心的经验。
Arch Dermatol Res. 2022 Jan;314(1):89-93. doi: 10.1007/s00403-020-02125-7. Epub 2020 Sep 4.
2
Squamous Cell Carcinoma In Situ Upstaged to Invasive Squamous Cell Carcinoma: A 5-Year, Single Institution Retrospective Review.原位鳞状细胞癌进展为浸润性鳞状细胞癌:一项为期5年的单机构回顾性研究。
Dermatol Surg. 2017 May;43(5):698-703. doi: 10.1097/DSS.0000000000001028.
3
Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.在接受 Mohs 显微外科手术的活检证实为原位鳞状细胞癌的患者中,侵袭性鳞状细胞癌的发生率。
Dermatol Surg. 2012 Sep;38(9):1456-60. doi: 10.1111/j.1524-4725.2012.02507.x. Epub 2012 Jun 26.
4
Squamous Cell Carcinoma In Situ With Occult Invasion: A Tertiary Care Institutional Experience.原位鳞状细胞癌伴隐匿性浸润:三级医疗机构的经验。
Dermatol Surg. 2019 Nov;45(11):1345-1352. doi: 10.1097/DSS.0000000000001841.
5
Squamous Cell Carcinoma in Situ Achieves Tumor Clearance in More Mohs Stages Than Invasive Squamous Cell Carcinoma.原位鳞状细胞癌比浸润性鳞状细胞癌需要更多的 Mohs 阶段来达到肿瘤清除。
Dermatol Surg. 2023 Dec 1;49(12):1104-1107. doi: 10.1097/DSS.0000000000004022. Epub 2023 Nov 15.
6
Mohs Micrographic Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma.Mohs 显微外科手术作为指甲单元鳞状细胞癌的标准治疗方法。
Dermatol Surg. 2020 Jun;46(6):725-732. doi: 10.1097/DSS.0000000000002144.
7
Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.评估局部 5-氟尿嘧啶作为原位鳞状细胞癌的主要和辅助治疗的结果。
Arch Dermatol Res. 2024 May 24;316(6):220. doi: 10.1007/s00403-024-02906-4.
8
A retrospective study of squamous cell carcinoma of the nail unit diagnosed in a Belgian general hospital over a 15-year period.比利时一家综合医院 15 年间诊断的甲单元鳞状细胞癌回顾性研究。
J Am Acad Dermatol. 2013 Aug;69(2):253-61. doi: 10.1016/j.jaad.2013.02.008. Epub 2013 Apr 9.
9
Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.评估鳞状细胞原位癌(SCCis)中毛囊浸润深度的组织病理学:对治疗方法的影响。
J Am Acad Dermatol. 2016 Feb;74(2):356-62. doi: 10.1016/j.jaad.2015.09.060. Epub 2015 Dec 6.
10
Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long-term follow-up.Mohs 手术治疗甲床鳞状细胞癌:15 例报告。我们的经验和长期随访。
Br J Dermatol. 2012 Dec;167(6):1310-4. doi: 10.1111/j.1365-2133.2012.11129.x.

引用本文的文献

1
A Review of the Histopathology of Nail Unit Tumors Including Selection of the Optimal Surgical Sampling.甲单位肿瘤的组织病理学综述,包括最佳手术取样的选择。
Skin Appendage Disord. 2024 Dec;10(6):443-458. doi: 10.1159/000539383. Epub 2024 Jul 15.
2
Update on Squamous Cell Carcinoma of the Nail Unit: An Human Papillomavirus-Associated Condition.甲单位鳞状细胞癌的最新进展:一种与人乳头瘤病毒相关的病症。
Skin Appendage Disord. 2024 Jun;10(3):199-206. doi: 10.1159/000537760. Epub 2024 Mar 8.
3
Nail Unit Squamous Cell Carcinoma with Onycholemmal Features: Case Report and Review of the Literature.具有甲母质特征的甲单位鳞状细胞癌:病例报告及文献复习
Skin Appendage Disord. 2023 Aug;9(4):284-290. doi: 10.1159/000529906. Epub 2023 Apr 14.

本文引用的文献

1
Mohs Micrographic Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma.Mohs 显微外科手术作为指甲单元鳞状细胞癌的标准治疗方法。
Dermatol Surg. 2020 Jun;46(6):725-732. doi: 10.1097/DSS.0000000000002144.
2
Nail squamous cell carcinoma: A hidden high-risk human papillomavirus reservoir for sexually transmitted infections.甲鳞状细胞癌:性传播感染的隐藏高危人乳头瘤病毒储库。
J Am Acad Dermatol. 2019 Dec;81(6):1358-1370. doi: 10.1016/j.jaad.2019.03.070. Epub 2019 Mar 29.
3
Squamous Cell Carcinoma In Situ With Occult Invasion: A Tertiary Care Institutional Experience.原位鳞状细胞癌伴隐匿性浸润:三级医疗机构的经验。
Dermatol Surg. 2019 Nov;45(11):1345-1352. doi: 10.1097/DSS.0000000000001841.
4
Squamous cell carcinoma of the nail unit.甲单位鳞状细胞癌。
Dermatol Pract Concept. 2018 Jul 31;8(3):238-244. doi: 10.5826/dpc.0803a17. eCollection 2018 Jul.
5
A Retrospective Study of Nail Squamous Cell Carcinoma at 2 Institutions.两家机构关于甲部鳞状细胞癌的回顾性研究。
Dermatol Surg. 2016 Jan;42 Suppl 1:S8-S17. doi: 10.1097/DSS.0000000000000521.
6
A retrospective study of squamous cell carcinoma of the nail unit diagnosed in a Belgian general hospital over a 15-year period.比利时一家综合医院 15 年间诊断的甲单元鳞状细胞癌回顾性研究。
J Am Acad Dermatol. 2013 Aug;69(2):253-61. doi: 10.1016/j.jaad.2013.02.008. Epub 2013 Apr 9.
7
Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases.人乳头瘤病毒相关的指部鳞状细胞癌:文献综述及21例新病例报告
J Am Acad Dermatol. 2003 Mar;48(3):385-93. doi: 10.1067/mjd.2003.184.

原位鳞状细胞癌在指甲单元中并不常见:来自三级癌症中心的经验。

Squamous cell carcinoma in situ upstaging is not frequent in the nail unit: a tertiary cancer center experience.

机构信息

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 530 East 73rd Street, New York, NY, 10021, USA.

Downstate Medical Center College of Medicine, Brooklyn, NY, USA.

出版信息

Arch Dermatol Res. 2022 Jan;314(1):89-93. doi: 10.1007/s00403-020-02125-7. Epub 2020 Sep 4.

DOI:10.1007/s00403-020-02125-7
PMID:32886149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9608379/
Abstract

Squamous cell carcinoma in situ (SCCIS) of the nail unit is a complex malignancy; with little understanding of rate of upstaging or occult invasion in these patients. We sought to evaluate the rate of upstaging in nail unit SCCIS after Mohs micrographic surgery (MMS). Retrospective review of 346 patients who referred for and underwent MMS for biopsy proven SCCIS on the hands and feet between January 1, 2000 and December 30, 2019. Only cases in the nail unit were included. Clinical, surgical details, histopathological features, HPV status, and rate of upstaging were recorded. Thirty-one cases met the inclusion criteria and were analyzed. Twenty-four patients were males (77.4%). The mean age was 55 years (SD 17.26, range 27-84). The mean clinical size was 9.9 mm; 19 cases tested for HPV, 15/19 were positive (78.9%), and 8/19 (42.1%) were associated with high-risk HPV. Three patients (9.7%) were upstaged to invasive on either MMS margins or tumor debulking. Limitations included a relatively small sample size and retrospective in nature. The rate of upstaging of SCCIS in the nail unit is not frequent, and when upstaging occurred it was focal, superficial, and with no PNI or bone invasion.

摘要

甲单元原位鳞状细胞癌(SCCIS)是一种复杂的恶性肿瘤,对于这些患者的升期率或隐匿性浸润了解甚少。我们旨在评估Mohs 显微外科手术(MMS)后甲单元 SCCIS 的升期率。回顾性分析了 2000 年 1 月 1 日至 2019 年 12 月 30 日期间因手部和足部活检证实的 SCCIS 而转诊并接受 MMS 的 346 例患者。仅纳入甲单元的病例。记录了临床、手术细节、组织病理学特征、HPV 状态和升期率。符合纳入标准的 31 例病例进行了分析。24 例为男性(77.4%)。平均年龄为 55 岁(SD 17.26,范围 27-84)。平均临床大小为 9.9mm;19 例检测 HPV,15/19 阳性(78.9%),8/19(42.1%)与高危型 HPV 相关。3 例(9.7%)在 MMS 边缘或肿瘤切除时升期为浸润性。局限性在于样本量相对较小且为回顾性研究。甲单元 SCCIS 的升期率不频繁,当升期时,呈局灶性、表浅性,且无 PNI 或骨浸润。